Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Tyra Biosciences, Inc. logo

Tyra Biosciences, Inc. (TYRA) Stock Ticker

NASDAQ: TYRA · Healthcare · Biotechnology
$21.76-2.90%
USD · as of 2026-09-28 · market cap $1.3B
Open TYRA in TickrDownload for iPhone

TYRA right now

22% of the float is sold short.
Options expect by Oct 6±9.2%
Options expect by Oct 29±19.1%
Priced in for Nov 4 earnings±21.0%
IV rank (30-day)9% · cheap
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full TYRA picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on TYRA
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Tyra Biosciences, Inc.

Tyra Biosciences, Inc. is a preclinical biopharmaceutical company focused on innovating treatments to tackle tumor resistance and enhance patient outcomes in oncology. Its flagship product candidate, TYRA-300, is a highly selective inhibitor of fibroblast growth factor receptor (FGFR)3, specifically engineered for the treatment of muscle-invasive bladder cancer. Beyond this, the company is advancing a pipeline of programs addressing other critical conditions, including FGFR2-related intrahepatic cholangiocarcinoma, FGFR3-associated achondroplasia, REarranged during transfection (RET) kinase aberrations, and various FGFR4-driven cancers. Tyra also leverages its proprietary SNAP platform, designed to accelerate structural drug design through an iterative molecular 'snapshot' approach. Founded in 2018, Tyra Biosciences maintains its headquarters in Carlsbad, California.

TYRA stock facts

Ticker symbolTYRA
ExchangeNASDAQ Global Select
SectorHealthcare
IndustryBiotechnology
Market cap$1.3B
CEOTodd Harris
Employees87
HeadquartersCarlsbad, CA, US
IPO date2021-09-15
Websitewww.tyra.bio

What you can see for TYRA on Tickr

Live TYRA price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the TYRA report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for Tyra Biosciences, Inc.?

The ticker symbol for Tyra Biosciences, Inc. is TYRA, listed on the NASDAQ Global Select.

What is TYRA?

Tyra Biosciences, Inc. is a preclinical biopharmaceutical company focused on innovating treatments to tackle tumor resistance and enhance patient outcomes in oncology. Its flagship product candidate, TYRA-300, is a highly selective inhibitor of fibroblast growth factor receptor (FGFR)3, specifically engineered for the treatment of muscle-invasive bladder cancer. Beyond this, the company is…

HomeExploreMarketLists
All pages